Nonclinical safety assessment of epigenetic modulatory drugs: Current status and industry perspective

Publication date: November 2020Source: Regulatory Toxicology and Pharmacology, Volume 117Author(s): Vincent L. Reynolds, Paul Butler, Matthew M. Abernathy, Laura Aschenbrenner, Derek D. Best, Jim Blank, Meredith Crosby, Laura Custer, Patricia A. Escobar, Kyle Kolaja, Jonathan Moggs, Dana Shuey, Chelsea Snyder, Terry Van Vleet, Junguo Zhou, Timothy K. Hart
Source: Regulatory Toxicology and Pharmacology - Category: Toxicology Source Type: research